In the second episode of Season 3, we spoke with Dr. Barthalomew Sillah, COO of Avesta76 therapeutics about his experiences turning innovative science into impactful therapeutics. Our conversation touched on being open-minded to new opportunities, learning from non-biotech experiences in the healthcare ecosystem, and championing inclusion in the industry.